Skin cancer and new treatment perspectives: a review.
暂无分享,去创建一个
J. Sousa | A. Pais | A. Pais | M. Simões | J J S Sousa | A A C C Pais | M C F Simões | J. Sousa | M. Simŏes
[1] N. Lowe. An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses. , 2006, Dermatologic clinics.
[2] Hua Yu,et al. Gene gun application in the generation of effector T cells for adoptive immunotherapy , 2000, Cancer Immunology, Immunotherapy.
[3] M. Willander,et al. Photodynamic effects of zinc oxide nanowires in skin cancer and fibroblast , 2014, Lasers in Medical Science.
[4] S. Franceschi,et al. Cutaneous malignant melanoma: epidemiological considerations. , 1992, Seminars in surgical oncology.
[5] S. Dowdy,et al. Protein transduction technology. , 2002, Current opinion in biotechnology.
[6] Katherine W Ferrara,et al. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.
[7] Naomi J Halas,et al. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.
[8] R. Heller,et al. Delivery of Interleukin-15 to B16 Melanoma by Electroporation Leads to Tumor Regression and Long-term Survival , 2014, Technology in cancer research & treatment.
[9] F. S. Ferreira,et al. Biodegradable polymeric nanocapsules based on poly(DL-lactide) for genistein topical delivery: obtention, characterization and skin permeation studies. , 2013, Journal of biomedical nanotechnology.
[10] S. Pazzaglia,et al. Basal Cell Carcinoma and Its Development , 2004, Cancer Research.
[11] Y. Kong,et al. Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 , 2014, Front. Immunol..
[12] C. Chiang,et al. Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. , 2014, Biomaterials.
[13] D. Irvine,et al. Enhancing radiotherapy by lipid nanocapsule-mediated delivery of amphiphilic gold nanoparticles to intracellular membranes. , 2014, ACS nano.
[14] Erik C. Dreaden,et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. , 2008, Cancer letters.
[15] A. Rook,et al. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma , 2014, Current opinion in oncology.
[16] L. Kemény,et al. [Electrochemotherapy of melanoma cutaneous metastases]. , 2010, Orvosi hetilap.
[17] S. Fulda,et al. Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell‐Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells , 2010, Stem cells.
[18] H. Horton,et al. IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial. , 2008, Methods in molecular biology.
[19] Hiroyuki Honda,et al. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma , 2003, Cancer Immunology, Immunotherapy.
[20] N. Sethy,et al. Cerium oxide nanoparticles prevent apoptosis in primary cortical culture by stabilizing mitochondrial membrane potential , 2014, Free radical research.
[21] C. Mai,et al. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers , 2013, OncoTargets and therapy.
[22] J. Mano,et al. Pectin-coated chitosan microgels crosslinked on superhydrophobic surfaces for 5-fluorouracil encapsulation. , 2013, Carbohydrate polymers.
[23] S. Jelveh,et al. Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics , 2011, Cancers.
[24] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[25] N. Rosales,et al. Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells. , 1989, The Journal of investigative dermatology.
[26] Jon J Briggs,et al. Immunostimulatory Effects of CpG-ODN Upon Dendritic Cell-Based Immunotherapy in a Murine Melanoma Model , 2004, Journal of immunotherapy.
[27] R. Parhi,et al. Preparation and characterization of solid lipid nanoparticles-a review. , 2012, Current drug discovery technologies.
[28] Eneida A. Mendonça,et al. A Phase III Skin Cancer Chemoprevention Study of DFMO: Long-term Follow-up of Skin Cancer Events and Toxicity , 2012, Cancer Prevention Research.
[29] Yifei Xing,et al. The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. , 2008, Biochemical and biophysical research communications.
[30] J. Adán,et al. In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles , 2014, International journal of nanomedicine.
[31] Vinayak Sant,et al. Graphene-based nanomaterials for drug delivery and tissue engineering. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[32] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[33] S. Calderwood. Molecular Cochaperones: Tumor Growth and Cancer Treatment , 2013, Scientifica.
[34] Stuart K. Calderwood,et al. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.
[35] Adèle C. Green,et al. Epidemiology of Malignant Melanoma , 2010 .
[36] A. Seifalian,et al. A new era of cancer treatment: carbon nanotubes as drug delivery tools , 2011, International journal of nanomedicine.
[37] P. Russell,et al. Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? , 2010, Stem cells.
[38] A. Chang,et al. Use of gene gun for genetic immunotherapy : in vitro and in vivo methods. , 2001, Methods in molecular medicine.
[39] Nathan Johnston,et al. Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. , 2014, Biomaterials.
[40] John A Thompson,et al. Treatment of metastatic melanoma: an overview. , 2009, Oncology.
[41] Hans Leuenberger,et al. Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique , 2004, Pharmaceutical Research.
[42] A. Stratigos,et al. Antiangiogenic and antiapoptotic treatment in advanced melanoma. , 2013, Clinics in dermatology.
[43] A. Vidimos,et al. Nonsurgical treatment of nonmelanoma skin cancer. , 2011, Dermatologic clinics.
[44] A. S. Sobolev,et al. Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo , 2012, Doklady Biochemistry and Biophysics.
[45] M. Anwer,et al. Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer , 2010, International journal of medical sciences.
[46] M. Blagosklonny. Selective anti-cancer agents as anti-aging drugs , 2013, Cancer biology & therapy.
[47] F. Pontén,et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer , 2001, Oncogene.
[48] Liping Tang,et al. Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles , 2008, Nanotechnology.
[49] N. Hioka,et al. An efficient rose bengal based nanoplatform for photodynamic therapy. , 2014, Chemistry.
[50] M. Lacouture,et al. Non-rash skin toxicities associated with novel targeted therapies. , 2006, Clinical lung cancer.
[51] N. Yang,et al. Gene gun delivery systems for cancer vaccine approaches. , 2009, Methods in molecular biology.
[52] U. Liebert,et al. Complex cancer gene therapy in mice melanoma , 2002, Langenbeck's Archives of Surgery.
[53] D. Schadendorf,et al. Lack of clinical efficacy of imatinib in metastatic melanoma , 2005, British Journal of Cancer.
[54] J. Willmann,et al. Ultrasound and Microbubble–Mediated Gene Delivery in Cancer: Progress and Perspectives , 2013, Investigative radiology.
[55] Chang-Sik Ha,et al. Synthesis and Drug‐Delivery Behavior of Chitosan‐Functionalized Graphene Oxide Hybrid Nanosheets , 2011 .
[56] Deevya L. Narayanan,et al. Review: Ultraviolet radiation and skin cancer , 2010, International journal of dermatology.
[57] Soumen Das,et al. Cerium oxide nanoparticles: applications and prospects in nanomedicine. , 2013, Nanomedicine.
[58] F. Hodi,et al. Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 , 2012, Clinical Cancer Research.
[59] Blazej Zbytek,et al. Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. , 2012, Advances in anatomy, embryology, and cell biology.
[60] E. Winer,et al. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. , 2001, Journal of the National Cancer Institute. Monographs.
[61] Rainer H Müller,et al. Lipid nanoparticles for parenteral delivery of actives. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[62] Zhuang Liu,et al. Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.
[63] C. Elmets,et al. Prospects for skin cancer treatment and prevention: the potential contribution of an engineered virus. , 2011, The Journal of investigative dermatology.
[64] A. S. Sobolev,et al. Engineered modular recombinant transporters: application of new platform for targeted radiotherapeutic agents to alpha-particle emitting 211 At. , 2008, International journal of radiation oncology, biology, physics.
[65] Carlos Roberto Antonio,et al. Nanotechnology in Dermatology* , 2014, Anais brasileiros de dermatologia.
[66] R. Saladi,et al. The causes of skin cancer: a comprehensive review. , 2005, Drugs of today.
[67] Cheri X Deng,et al. Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.
[68] A. S. Sobolev. Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency , 2009, Biochemistry (Moscow).
[69] Laura Marcu,et al. In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies , 2007, International journal of cancer.
[70] R. Orecchia,et al. Radiotherapy-induced ear toxicity. , 2003, Cancer treatment reviews.
[71] D. Morton,et al. Surgery for distant melanoma metastasis. , 2012, Cancer journal.
[72] C. Dispenza,et al. Polymeric Nanogels: Nanocarriers For Drug Delivery Application , 2012 .
[73] P. Ascierto,et al. Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon , 2014, Journal of chemotherapy.
[74] Xiaohua Huang,et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.
[75] J. Belanger. Perillyl alcohol: applications in oncology. , 1998, Alternative medicine review : a journal of clinical therapeutic.
[76] Brett M. Coldiron,et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.
[77] C. Morton,et al. Guidelines for the management of basal cell carcinoma , 2008, The British journal of dermatology.
[78] J. West,et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. , 2005, Nano letters.
[79] Yu-Ying He,et al. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. , 2009, Toxicology and applied pharmacology.
[80] Michael J Sailor,et al. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. , 2008, Angewandte Chemie.
[81] A. Hauschild,et al. Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] Sandra C. Mwakwari,et al. Historic perspective on the use of AuNPs in medicine , 2008 .
[83] F. Marincola,et al. Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy , 2014, Archives of Dermatological Research.
[84] A. Enk,et al. Genetic immunization of mice with human tyrosinase‐related protein 2: Implications for the immunotherapy of melanoma , 2000, International journal of cancer.
[85] Jyothi U. Menon,et al. Nanomaterials for Photo-Based Diagnostic and Therapeutic Applications , 2013, Theranostics.
[86] J. Dai,et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. , 2012, ACS applied materials & interfaces.
[87] J. Rivers. The detection and management of dysplastic nevi and early melanoma , 1992, World Journal of Surgery.
[88] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[89] Yu Shyr,et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. , 2012, The New England journal of medicine.
[90] A. Sieroń,et al. Photodynamic therapy in treatment of cutaneous and choroidal melanoma. , 2013, Photodiagnosis and photodynamic therapy.
[91] B. Michniak-Kohn,et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[92] Robert E. Nordquist,et al. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients , 2010, Cancer biology & therapy.
[93] D. Alberts,et al. Chemoprevention of Human Actinic Keratoses by Topical dl-α-tocopherol , 2009, Cancer Prevention Research.
[94] S. Mitragotri,et al. Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound , 2005, British Journal of Cancer.
[95] Y. Lim,et al. Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy. , 2014, Biomaterials.
[96] A. Geller,et al. Epidemiology of melanoma and nonmelanoma skin cancer. , 2003, Seminars in oncology nursing.
[97] J. Kristl,et al. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. , 2010, International journal of pharmaceutics.
[98] M. Guan,et al. Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[99] R. Gutzmer,et al. Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas , 2008, British Journal of Cancer.
[100] John Ballato,et al. Single-cell-level microplasma cancer therapy. , 2011, Small.
[101] L. Zitvogel,et al. The Critical Role of IL-15 in the Antitumor Effects Mediated by the Combination Therapy Imatinib and IL-21 , 2008, The Journal of Immunology.
[102] Xin Li,et al. The preparation and drug delivery of a graphene-carbon nanotube-Fe3O4 nanoparticle hybrid. , 2013, Journal of materials chemistry. B.
[103] A. Nomizo,et al. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles. , 2014, Journal of biomedical nanotechnology.
[104] Reinhard Dummer,et al. Skin cancer : a world-wide perspective , 2011 .
[105] Hicham A. Chibli,et al. Comparative cytotoxicity of gold–doxorubicin and InP–doxorubicin conjugates , 2012, Nanotechnology.
[106] Sikandar G. Khan,et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. , 2005, Carcinogenesis.
[107] F. Rossetti,et al. PLGA nanoparticles as delivery systems for protoporphyrin IX in topical PDT: cutaneous penetration of photosensitizer observed by fluorescence microscopy. , 2013, Journal of nanoscience and nanotechnology.
[108] K. Tanabe,et al. Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review , 2014, The British journal of dermatology.
[109] J. McCubrey,et al. Molecular targeted therapy in melanoma: a way to reverse resistance to conventional drugs. , 2012, Current drug delivery.
[110] K. Madison,et al. Barrier function of the skin: "la raison d'être" of the epidermis. , 2003, The Journal of investigative dermatology.
[111] K. Flaherty,et al. Melanoma: new insights and new therapies. , 2012, The Journal of investigative dermatology.
[112] C. Garland,et al. Rising trends in melanoma. An hypothesis concerning sunscreen effectiveness. , 1993, Annals of epidemiology.
[113] J. Eberle,et al. BH3‐only proteins – possible proapoptotic triggers for melanoma therapy , 2014, Experimental dermatology.
[114] N. Khlebtsov,et al. Gold nanoparticles in biomedical applications: recent advances and perspectives. , 2012, Chemical Society reviews.
[115] X. Liang,et al. [The use of gene gun in cancer gene therapy]. , 2000, Zhonghua yi xue za zhi.
[116] Wenyi Wei,et al. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer. , 2013, Journal of genetics and genomics = Yi chuan xue bao.
[117] Guy Vallancien,et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.
[118] A. Eggermont,et al. Advances in systemic treatment of melanoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[119] R. Lopez,et al. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. , 2010, Journal of pharmaceutical and biomedical analysis.
[120] Soumen Das,et al. Combination of Conventional Chemotherapeutics with Redox-Active Cerium Oxide Nanoparticles—A Novel Aspect in Cancer Therapy , 2014, Molecular Cancer Therapeutics.
[121] A. Slominski,et al. Neuroendocrinology of the skin. , 2000, Endocrine reviews.
[122] A. Jindal,et al. Nanocarriers and nanoparticles for skin care and dermatological treatments , 2013, Indian dermatology online journal.
[123] E. Celis,et al. A novel combinatorial cancer immunotherapy , 2014, Oncoimmunology.
[124] A. Bosserhoff,et al. Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells , 2013, Experimental dermatology.
[125] Zhijun Zhang,et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. , 2010, Small.
[126] S. Karrer,et al. Neue Entwicklungen in der photodynamischen Therapie , 2013, Der Hautarzt.
[127] A. Tedesco,et al. Quantitative approach to skin field cancerization using a nanoencapsulated photodynamic therapy agent: a pilot study , 2013, Clinical, cosmetic and investigational dermatology.
[128] S. Nair,et al. Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. , 2013, Carbohydrate polymers.
[129] P. Workman,et al. Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.
[130] K. K. Singh,et al. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[131] James T. Elder,et al. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. , 2007, The American journal of pathology.
[132] J H Senior,et al. Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.
[133] G. Weiner,et al. CpG oligodeoxynucleotides as immunotherapy in cancer. , 2008, Update on cancer therapeutics.
[134] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[135] T. Wu,et al. Enhancement of Tumor-Specific T Cell–Mediated Immunity in Dendritic Cell–Based Vaccines by Mycobacterium tuberculosis Heat Shock Protein X , 2014, The Journal of Immunology.
[136] R. Velmurugan,et al. Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy , 2012, Lipids in Health and Disease.
[137] A P Cullen,et al. The human health effects of ozone depletion and interactions with climate change , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[138] N. Hayward,et al. Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4R24C/R24C/Tyr‐NrasQ61K mice following neonatal UVR , 2010, Pigment cell & melanoma research.
[139] R. Asmatulu,et al. Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model. , 2013, Journal of biotechnology.
[140] Á. Villanueva,et al. Metallo‐naphthalocyanines as photothermal sensitisers for experimental tumours: In Vitro and in vivo studies , 2009, Lasers in surgery and medicine.
[141] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[142] Dapeng Liu,et al. Synthesis of 3D Hierarchical Fe3O4/Graphene Composites with High Lithium Storage Capacity and for Controlled Drug Delivery , 2011 .
[143] A. Akbarzadeh,et al. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine , 2012, Nanoscale Research Letters.
[144] H. Gensler. Prevention byα-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation , 2005, Journal of Cancer Research and Clinical Oncology.
[145] C. Vachon,et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. , 2007, Mayo Clinic proceedings.
[146] K. Togsverd-Bo,et al. [Organ transplant recipients need intensive control and treatment of skin cancer]. , 2013, Ugeskrift for laeger.
[147] N. Smith. Applications of ultrasonic skin permeation in transdermal drug delivery , 2008, Expert opinion on drug delivery.
[148] S. Ugurel,et al. Skin toxicity of anti‐cancer therapy , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[149] A. Sarasin,et al. The molecular pathways of ultraviolet-induced carcinogenesis. , 1999, Mutation research.
[150] Hiroyuki Koide,et al. The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo , 2011, Proceedings of the National Academy of Sciences.
[151] D. Miklavčič,et al. Modulation of Activity of Known Cytotoxic Ruthenium(III) Compound (KP418) with Hampered Transmembrane Transport in Electrochemotherapy In Vitro and In Vivo , 2014, The Journal of Membrane Biology.
[152] J. A. Bishop,et al. British Association of Dermatologists Clinical Standards Unit. Revised U.K. guidelines for the management of cutaneous melanoma , 2010 .
[153] E. Traversa,et al. The effect of cerium valence states at cerium oxide nanoparticle surfaces on cell proliferation. , 2014, Biomaterials.
[154] T. Liu,et al. Epidemiology of malignant melanoma. , 1996, The Surgical clinics of North America.
[155] Randy Gordon,et al. Skin cancer: an overview of epidemiology and risk factors. , 2013, Seminars in oncology nursing.
[156] Amarnath Sharma,et al. Liposomes in drug delivery: Progress and limitations , 1997 .
[157] Joseph Kost,et al. Ultrasound and transdermal drug delivery. , 2004, Drug discovery today.
[158] E. Rosenthal,et al. Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. , 2013, International journal of radiation oncology, biology, physics.
[159] B. Armstrong,et al. The epidemiology of UV induced skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.
[160] P. Workman,et al. Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics. , 2012, Annual review of pharmacology and toxicology.
[161] R. Cavalli,et al. Solid lipospheres of doxorubicin and idarubicin , 1993 .
[162] Lin Mei,et al. Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics , 2014, Theranostics.
[163] G. Yener,et al. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives , 2007, International journal of nanomedicine.
[164] D. Mukhopadhyay,et al. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. , 2008, Cancer research.
[165] C. Horak,et al. Nivolumab plus ipilimumab in advanced melanoma. , 2013, The New England journal of medicine.
[166] M. Andreeff,et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.
[167] Xiaohua Huang,et al. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.
[168] C. Otley,et al. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. , 2001, Mayo Clinic proceedings.
[169] D. Davies,et al. TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population , 2010, British Journal of Cancer.
[170] P. Hersey,et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy) , 2005, Melanoma research.
[171] M Keidar,et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy , 2011, British Journal of Cancer.
[172] Hui Zhang,et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. , 2007, Nano letters.
[173] Sikandar G. Khan,et al. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma , 2005, European Journal of Human Genetics.
[174] G. Choi,et al. Inhibition of c-Kit signaling by diosmetin isolated from Chrysanthemum morifolium , 2013, Archives of pharmacal research.
[175] S. Nair,et al. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. , 2012, Nanoscale.
[176] Dan Peer,et al. Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles. , 2014, Nanoscale.
[177] J. Blenis,et al. Phosphorylation of p90 Ribosomal S6 Kinase (RSK) Regulates Extracellular Signal-Regulated Kinase Docking and RSK Activity , 2003, Molecular and Cellular Biology.
[178] Takeshi Mori,et al. Poly(ethylene glycol)-Modified Gold Nanorods as a Photothermal Nanodevice for Hyperthermia , 2009, Journal of biomaterials science. Polymer edition.
[179] I. L. Le Poole,et al. HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. , 2008, The Journal of investigative dermatology.
[180] S. Hsu,et al. Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy. , 2013, Nanomedicine.
[181] R. Duncan,et al. Dendrimer-platinate: a novel approach to cancer chemotherapy. , 1999, Anti-cancer drugs.
[182] Mira Kim,et al. A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo , 2012 .
[183] F. Farzaneh,et al. Protein transduction: an alternative to genetic intervention? , 2001, Gene Therapy.
[184] Stanley J. Miller,et al. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery , 2010, International journal of dermatology.
[185] A. S. Sobolev,et al. Recombinant modular transporters for cell‐specific nuclear delivery of locally acting drugs enhance photosensitizer activity , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[186] Yi Sun,et al. Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets. , 2010, Genes & cancer.
[187] Victoria L. Lazareth,et al. Management of non-melanoma skin cancer. , 2013, Seminars in oncology nursing.
[188] T. Hieken,et al. Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables , 2008, Annals of Surgical Oncology.
[189] N. Hayward,et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.
[190] S. Amini,et al. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. , 2010, The Journal of clinical and aesthetic dermatology.
[191] F. Garbagnati,et al. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes. , 2006, Anticancer research.
[192] P. Uribe,et al. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. , 2011, Pathology, research and practice.
[193] M. Ferrarini,et al. Constitutive expression of the heat shock protein 72 kDa in human melanoma cells. , 1994, Cancer letters.
[194] Di Chen,et al. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[195] S. Jarrett,et al. UV Radiation and the Skin , 2013, International journal of molecular sciences.
[196] Kinam Park,et al. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. , 2012, Colloids and surfaces. B, Biointerfaces.
[197] Eviatar Nevo,et al. Genetic variation in nature , 2011, Scholarpedia.
[198] P. Ascierto,et al. Update on PEG-interferon α-2b as adjuvant therapy in melanoma. , 2012, Anticancer research.
[199] Kullervo Hynynen,et al. Overview of Therapeutic Ultrasound Applications and Safety Considerations , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[200] Q. Wei,et al. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non‐Hispanic whites in Texas: A case–control study , 2008, International journal of cancer.
[201] Alfonso Latorre,et al. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. , 2014, Nanoscale.
[202] Juergen F. Kolb,et al. A new pulsed electric field therapy for melanoma disrupts the tumor's blood supply and causes complete remission without recurrence , 2009, International journal of cancer.
[203] Prashant K. Jain,et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles , 2008, Lasers in Medical Science.
[204] R. Braga,et al. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[205] Forrest M Kievit,et al. Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers , 2011, Advanced materials.
[206] M. Bryszewska,et al. Dendrimers: properties and applications. , 2001, Acta biochimica Polonica.
[207] Yong-Yeon Cho,et al. A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer , 2013, Front. Oncol..
[208] Lin Li,et al. Water‐Soluble Poly(N‐isopropylacrylamide)–Graphene Sheets Synthesized via Click Chemistry for Drug Delivery , 2011 .
[209] S. Benita,et al. A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure , 1993 .
[210] C. El-Haibi,et al. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[211] Jennifer L. West,et al. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines , 2007, Journal of Neuro-Oncology.
[212] I. Guzhova,et al. Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool , 2012, Cell Stress and Chaperones.
[213] Javed Ali,et al. Nanostructured lipid carriers system: Recent advances in drug delivery , 2012, Journal of drug targeting.
[214] K. Finegan,et al. Molecular and Cellular Pathobiology the Mitogen-activated Protein Kinase Kinase 4 Has a Pro-oncogenic Role in Skin Cancer , 2022 .
[215] W. Byrne,et al. Enhancement of electroporation facilitated immunogene therapy via T-reg depletion , 2014, Cancer Gene Therapy.
[216] B. Nickoloff,et al. Life and death signaling pathways contributing to skin cancer. , 2002, The journal of investigative dermatology. Symposium proceedings.
[217] K. Nguyen,et al. Multifunctional particles for melanoma-targeted drug delivery. , 2012, Acta biomaterialia.
[218] J. Aitken,et al. Clinical practice guidelines for the management of melanoma in Australia and New Zealand , 2008 .
[219] Alan Ashworth,et al. Translating cancer research into targeted therapeutics , 2010, Nature.
[220] Richard Heller,et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[221] Rochlitz Cf. Gene therapy of cancer. , 2001 .
[222] P. Schiller,et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.
[223] R. Müller,et al. Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery , 2008, Drug development and industrial pharmacy.
[224] J. Pardeike,et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. , 2007, Advanced drug delivery reviews.
[225] B. Müller,et al. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[226] Galo J. A. A. Soler-Illia,et al. Hyaluronan degrading silica nanoparticles for skin cancer therapy. , 2013, Nanoscale.
[227] John H. Zhang,et al. Cold Atmospheric Plasma: methods of production and application in dentistry and oncology , 2013, Medical gas research.
[228] Sonke Svenson,et al. Dendrimers as versatile platform in drug delivery applications. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[229] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[230] Kostas Kostarelos,et al. Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. , 2009, Molecular pharmaceutics.
[231] J M Dubernard,et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. , 2000, Journal of endourology.
[232] P. Potter,et al. Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. , 2010, Current stem cell research & therapy.
[233] P. Dobbin,et al. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates , 2007, Molecular Cancer Therapeutics.
[234] Tzung-Han Chou,et al. The molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation. , 2009, Chemical research in toxicology.
[235] T. Tüting,et al. Biolistic DNA vaccination against melanoma. , 2013, Methods in molecular biology.
[236] J. Mark Elwood,et al. Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.
[237] M. H. Santana,et al. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery , 2011, Journal of drug delivery.
[238] A. Hauschild,et al. Optimization of photodynamic therapy with a novel self‐adhesive 5‐aminolaevulinic acid patch: results of two randomized controlled phase III studies , 2009, The British journal of dermatology.
[239] B. Logan,et al. The Skin Cancer Index: Clinical Responsiveness and Predictors of Quality of Life , 2007, The Laryngoscope.
[240] D. A. Russell,et al. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. , 2010, European journal of cancer.
[241] Yuquan Wei,et al. A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[242] D. Crommelin,et al. Liposomal and Lipid Formulations of Amphotericin B , 1992, Clinical pharmacokinetics.
[243] R. Dronca,et al. Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma. , 2014, Mayo Clinic proceedings.
[244] M. Aickin,et al. Importance of the form of topical vitamin E for prevention of photocarcinogenesis. , 1996, Nutrition and cancer.
[245] Baowei Fei,et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.
[246] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[247] Massoud Motamedi,et al. Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. , 2009, Nano letters.
[248] J. Reichrath. Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas , 2006 .
[249] M. Gore,et al. Revised UK guidelines for the management of cutaneous melanoma 2010. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[250] J. Kennedy. High-intensity focused ultrasound in the treatment of solid tumours , 2005, Nature Reviews Cancer.
[251] M. Wirth,et al. Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death , 2010, Nanotechnology.
[252] Y. Tabata,et al. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[253] N. Zhang,et al. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. , 2011, Colloids and surfaces. B, Biointerfaces.
[254] C. Hauge,et al. RSK and MSK in MAP kinase signalling , 2006, Journal of Cell Science.
[255] W. D. de Jong,et al. Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.
[256] S. Rosso,et al. Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study , 2007, BMC public health.
[257] H. Merk,et al. Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate , 2014, Skin Pharmacology and Physiology.
[258] C. Montero-Menei,et al. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. , 2011, Biomaterials.
[259] P. Wolf,et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study , 2001, The Lancet.
[260] D. Maria,et al. Association of daunorubicin to a lipid nanoemulsion that binds to low‐density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma‐bearing mice , 2014, The Journal of pharmacy and pharmacology.
[261] M. Pomplun,et al. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer , 2010, Cancer Prevention Research.
[262] P. Clarke. Nonmelanoma skin cancers - treatment options. , 2012, Australian family physician.
[263] K. Flaherty. Targeting metastatic melanoma. , 2012, Annual review of medicine.
[264] G. Rossi,et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.
[265] Leaf Huang,et al. Targeted nanoparticles deliver siRNA to melanoma. , 2010, The Journal of investigative dermatology.
[266] G. Robertson,et al. Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development , 2008, Clinical Cancer Research.
[267] M. Edidin,et al. Nanoscale artificial antigen presenting cells for T cell immunotherapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[268] F. T. ten Cate,et al. Radionuclide tumour therapy with ultrasound contrast microbubbles. , 2004, Ultrasonics.
[269] Karsten Mäder,et al. Solid lipid nanoparticles , 2012 .
[270] Brett M Coldiron,et al. No end in sight: the skin cancer epidemic continues. , 2011, Seminars in cutaneous medicine and surgery.
[271] Tej B. Shrestha,et al. Stem cell-based photodynamic therapy , 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[272] H. Dai,et al. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. , 2005, Journal of the American Chemical Society.
[273] Ivan H. El-Sayed,et al. Nanotechnology in Head and Neck Cancer: The Race Is On , 2010, Current oncology reports.
[274] A. Tedesco,et al. Photophysical studies and in vitro skin permeation/retention of Foscan/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. , 2008, Journal of nanoscience and nanotechnology.
[275] J. Cadeddu,et al. Efficacy of laser-activated gold nanoshells in ablating prostate cancer cells in vitro. , 2007, Journal of endourology.
[276] Ya-ju Chang,et al. Phospholipid-functionalized mesoporous silica nanocarriers for selective photodynamic therapy of cancer. , 2013, Biomaterials.
[277] D. Wallace. Mitochondria and cancer , 2012, Nature Reviews Cancer.
[278] D. Alberts,et al. Phase 1 Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer , 2008, Nutrition and cancer.
[279] C. Der,et al. Inhibition of Ras for cancer treatment: the search continues. , 2011, Future medicinal chemistry.
[280] Tzeng-Ji Chen,et al. Amiodarone and the risk of cancer , 2013, Cancer.
[281] Jie Huang,et al. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector , 2011 .
[282] H. Kılıç,et al. Femtosecond laser induced photodynamic therapy on 5-ALA treated SKMEL-30 cells: an efficient theranostic strategy to combat melanoma. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[283] J. L. van Delft,et al. The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye. , 1989, Investigative ophthalmology & visual science.
[284] Jia-bi Zhu,et al. Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration , 1999, Pharmaceutical Research.
[285] Y. Huang,et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk , 2008, Journal of Human Genetics.
[286] Z. Lou,et al. The cytotoxicity of OPA-modified CdSe/ZnS core/shell quantum dots and its modulation by silibinin in human skin cells. , 2011, Journal of Biomedical Nanotechnology.
[287] P. Bartels,et al. A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer , 2010, Cancer Prevention Research.
[288] Tarek R. Fadel,et al. A carbon nanotube-polymer composite for T-cell therapy. , 2014, Nature nanotechnology.
[289] Leon Hirsch,et al. Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.
[290] J. Wolchok,et al. At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy , 2013, Journal of leukocyte biology.
[291] J. Wenzel,et al. Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospects. , 2008, Handbook of experimental pharmacology.
[292] Taeghwan Hyeon,et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. , 2010, Journal of the American Chemical Society.
[293] V. de Giorgi,et al. Cutaneous toxicities of BRAF inhibitors: clinical and pathological challenges and call to action. , 2013, Critical reviews in oncology/hematology.
[294] A. Baccarelli,et al. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk , 2004, British Journal of Cancer.
[295] Probal Banerjee,et al. In-situ immobilization of quantum dots in polysaccharide-based nanogels for integration of optical pH-sensing, tumor cell imaging, and drug delivery. , 2010, Biomaterials.
[296] Elaine Fuchs,et al. Scratching the surface of skin development , 2007, Nature.
[297] A. Aplin,et al. Paying "particle" attention to novel melanoma treatment strategies. , 2010, The Journal of investigative dermatology.
[298] G. Singh,et al. Mitochondria and Cancer: Past, Present, and Future , 2013, BioMed research international.
[299] G. Peters. Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. , 2008, Journal of the National Cancer Institute.
[300] Zhuang Liu,et al. Graphene based gene transfection. , 2011, Nanoscale.
[301] D. Schadendorf,et al. Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma , 2004, Oncology Research and Treatment.
[302] Richard Heller,et al. Electroporation gene therapy preclinical and clinical trials for melanoma. , 2010, Current gene therapy.
[303] H. Pehamberger. Perspectives of pegylated interferon use in dermatological oncology. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[304] L. Naldi,et al. The epidemiology of skin cancer , 2002, The British journal of dermatology.
[305] R. Patlolla,et al. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery , 2010, Molecular membrane biology.
[306] A. Daud,et al. Plasmid IL-12 electroporation in melanoma , 2012, Human vaccines & immunotherapeutics.
[307] M. Üner. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. , 2006, Die Pharmazie.
[308] T. Xia,et al. Toxic Potential of Materials at the Nanolevel , 2006, Science.
[309] A. S. Sobolev,et al. Targeting cancer cells by novel engineered modular transporters. , 2006, Cancer research.
[310] J. Leoni,et al. Cyclooxygenase-2 Overexpression in Non-Melanoma Skin Cancer: Molecular Pathways Involved as Targets for Prevention and Treatment , 2011 .
[311] C. Chiang,et al. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation. , 2014, Small.
[312] C. Garbe,et al. New landscape in the treatment of melanoma: a 2012 update , 2013, Oncologie.
[313] P. Selvaraj,et al. A novel microparticulate vaccine for melanoma cancer using transdermal delivery , 2011, Journal of microencapsulation.
[314] Gregory Fridman,et al. Floating Electrode Dielectric Barrier Discharge Plasma in Air Promoting Apoptotic Behavior in Melanoma Skin Cancer Cell Lines , 2007 .
[315] Zhuoxuan Lu,et al. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. , 2011, Small.
[316] J. Pardeike,et al. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. , 2009, International journal of pharmaceutics.
[317] F. Ghiringhelli,et al. Stratégies vaccinales contre le mélanome , 2006 .
[318] A. Elaissari,et al. Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .
[319] D. Schadendorf. Gene-based therapy of malignant melanoma. , 2002, Seminars in oncology.
[320] G. Botti,et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis , 2013, BMC Cancer.
[321] Tingting Zheng,et al. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery , 2011 .
[322] P. Boyle,et al. Cancer of the skin: a forgotten problem in Europe. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[323] Do Hee Keum,et al. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer. , 2014, ACS nano.
[324] D. Hirst,et al. Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.
[325] A. Kabanov,et al. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. , 2009, Angewandte Chemie.
[326] S. Saraf,et al. Biocompatible nanoparticles for sustained topical delivery of anticancer phytoconstituent quercetin. , 2013, Pakistan journal of biological sciences : PJBS.
[327] A. Hauschild,et al. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[328] Zhuang Liu,et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.
[329] M. Nango,et al. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery. , 2014, Biochemical and biophysical research communications.
[330] G. Robertson,et al. Use of liposomes as drug delivery vehicles for treatment of melanoma , 2009, Pigment cell & melanoma research.
[331] F. Iza,et al. Air plasma coupled with antibody-conjugated nanoparticles: a new weapon against cancer , 2009 .
[332] A. Offidani,et al. Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases , 2014, Dermatologic therapy.
[333] Friedrich P Thinnes. Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk , 2013, Neurology.
[334] U. Liebert,et al. Antitumoral and antimetastatic effects of continuous particle-mediated cytokine gene therapy. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[335] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[336] T. Andresen,et al. Hyaluronic acid immobilized polyacrylamide nanoparticle sensors for CD44 receptor targeting and pH measurement in cells. , 2012, Bioconjugate chemistry.
[337] Aditya K. Gupta,et al. Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. , 2004, Cutis.
[338] J. Bordeaux,et al. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. , 2013, Clinics in dermatology.
[339] Y. Tomer,et al. Opportunistic autoimmune disorders , 2010, Annals of the New York Academy of Sciences.
[340] T. Desser,et al. New technologies in clinical ultrasound. , 2013, Seminars in roentgenology.
[341] Indrajit Roy,et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.
[342] Hugh M Gloster,et al. Skin cancer in skin of color. , 2006, Journal of the American Academy of Dermatology.
[343] D Miklavcic,et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[344] D. Rigel,et al. Epidemiology of melanoma. , 2010, Seminars in cutaneous medicine and surgery.
[345] Chengxiang Li,et al. In Vivo Evidences of Nanosecond Pulsed Electric Fields for Melanoma Malignancy Treatment on Tumor-Bearing BALB/c Nude Mice , 2014, Technology in cancer research & treatment.
[346] R. Rao,et al. Sonophoresis: recent advancements and future trends , 2009, The Journal of pharmacy and pharmacology.
[347] A. Olszanski. Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma , 2014, Journal of managed care & specialty pharmacy.
[348] Ponti Giovanni,et al. Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas , 2014, Disease Markers.
[349] Chitta Ranjan Patra,et al. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. , 2010, Advanced drug delivery reviews.
[350] M. López-Quintela,et al. Penetration of metallic nanoparticles in human full-thickness skin. , 2007, The Journal of investigative dermatology.
[351] Alessandro Testori,et al. Utility of electrochemotherapy in melanoma treatment , 2012, Current opinion in oncology.
[352] Jinhua Xu,et al. Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. , 2013, Molecular medicine reports.
[353] Tomoyuki Miyagawa,et al. Inhibition of Hsp90 and 70 sensitizes melanoma cells to hyperthermia using ferromagnetic particles with a low Curie temperature , 2014, International Journal of Clinical Oncology.
[354] Stanley J. Miller,et al. Mohs Surgery for the Treatment of Melanoma in Situ: A Review , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[355] K. Plichta,et al. Radiotherapy for cutaneous malignancies of the head and neck , 2013 .
[356] Qiang Wu,et al. The therapeutic efficacy of CdTe and CdSe quantum dots for photothermal cancer therapy. , 2012, Biomaterials.
[357] K. Flaherty,et al. Targeting the RAS pathway in melanoma. , 2012, Trends in molecular medicine.
[358] Kate S. Carroll,et al. Downregulation of tumor growth and invasion by redox-active nanoparticles. , 2013, Antioxidants & redox signaling.
[359] G. Colditz,et al. Genetic Variation in XPD, Sun Exposure, and Risk of Skin Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[360] P. Kabouridis. Biological applications of protein transduction technology. , 2003, Trends in biotechnology.
[361] Kevin B. Kim,et al. Dabrafenib for treatment of BRAF-mutant melanoma , 2013, Pharmacogenomics and personalized medicine.
[362] M. Prato,et al. Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. , 2009, Small.
[363] Ralph Weissleder,et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.
[364] Rainer H. Müller,et al. 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications , 2011 .
[365] N. Comfere,et al. Molecular targeted therapies in metastatic melanoma , 2013, Pharmacogenomics and personalized medicine.
[366] T. Sasada,et al. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy. , 2014, Nanomedicine.
[367] F. Szoka,et al. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. , 2008, Molecular pharmaceutics.
[368] A. Chang,et al. Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations , 2014, Current Dermatology Reports.
[369] Mark Borden,et al. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.
[370] C. Sung,et al. Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes , 2013, Nanotechnology.
[371] D. Schadendorf,et al. Gene-based immunotherapy of skin cancers. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[372] Lin Li,et al. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. , 2011, Chemical communications.
[373] Mansoor Amiji,et al. Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery , 2002, Pharmaceutical Research.
[374] N. Kanikkannan. Iontophoresis-Based Transdermal Delivery Systems , 2012, BioDrugs.
[375] J. Hainfeld,et al. The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.
[376] R. Tang,et al. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier. , 2015, Small.
[377] J. Naeyaert,et al. Understanding the trends in melanoma incidence and mortality: where do we stand? , 2000, European journal of dermatology : EJD.
[378] M. Małecki,et al. siRNA preparations in gene therapy of melanoma. , 2013, Medycyna wieku rozwojowego.
[379] P. Fisher,et al. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity. , 2013, Cancer research.
[380] O. Shakhova. Neural crest stem cells in melanoma development , 2014, Current opinion in oncology.
[381] Wei Lu,et al. Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres , 2009, Clinical Cancer Research.
[382] Yuan Ping,et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. , 2011, Small.
[383] Mark R Prausnitz,et al. Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. , 2003, Ultrasound in medicine & biology.
[384] A. Hauschild,et al. Surgery and radiotherapy in the treatment of cutaneous melanoma , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[385] T. H. Nguyen,et al. Nonmelanoma skin cancer , 2002, Current treatment options in oncology.
[386] M. Fu,et al. Induction of protective and therapeutic antitumour immunity using a novel tumour‐associated antigen‐specific DNA vaccine , 2006, Immunology and cell biology.
[387] H. Geng,et al. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD‐1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma , 2006, International journal of cancer.
[388] A. Lu,et al. Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.
[389] M. Fu,et al. [Antitumor effect of gene gun-mediated DNA vaccine pWRG-neu immunization in C57BL/6 mice]. , 2003, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[390] A. Stratigos,et al. Emerging trends in the epidemiology of melanoma , 2014, The British journal of dermatology.
[391] E. Unger,et al. Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.
[392] Murad Alam,et al. Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[393] H. Gollnick,et al. Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. , 2004, The Journal of investigative dermatology.
[394] K. Char,et al. Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. , 2013, Small.
[395] H. Mitsui,et al. Novel immunotherapeutic approaches to skin cancer treatments using protein transduction technology. , 2011, Journal of dermatological science.
[396] Josep Malvehy,et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. , 2012, European journal of cancer.
[397] C. Puglia,et al. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals , 2012, Expert opinion on drug delivery.
[398] J. S. Mulliken,et al. The effect of sunscreen on melanoma risk. , 2002, Dermatologic clinics.
[399] A. Melcher,et al. Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas , 2006, The Journal of Immunology.
[400] E. E. Carpenter,et al. Chemically prepared magnetic nanoparticles , 2004 .
[401] J. Uitto,et al. The gene gun: current applications in cutaneous gene therapy , 2000, International journal of dermatology.
[402] Yi Sun,et al. SCF E3 ubiquitin ligases as anticancer targets. , 2011, Current cancer drug targets.
[403] S. Bossmann,et al. Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. , 2010, ACS nano.
[404] A. Berger,et al. RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells. , 2014, The Journal of investigative dermatology.
[405] F. Gruijl. Skin cancer and solar UV radiation , 1999 .
[406] M. Andreeff,et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.
[407] M. Mihm,et al. CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS , 2008, Nature Clinical Practice Oncology.
[408] Peter McLoughlin,et al. Microneedle mediated delivery of nanoparticles into human skin. , 2009, International journal of pharmaceutics.
[409] M. Woodle,et al. Sterically stabilized liposome therapeutics , 1995 .
[410] L. Löfgren,et al. Electroporation Therapy of Skin Cancer in the Head and Neck Area , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[411] H. Noguchi,et al. Protein transduction technology: a novel therapeutic perspective. , 2006, Acta medica Okayama.
[412] Yong-Yeon Cho,et al. RSK2 as a key regulator in human skin cancer. , 2012, Carcinogenesis.
[413] Il-Kwon Oh,et al. Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. , 2011, Bioconjugate chemistry.
[414] Dar-Bin Shieh,et al. Nanoshell Magnetic Resonance Imaging Contrast Agents , 2007, 2007 Digest of papers Microprocesses and Nanotechnology.
[415] V. del Marmol,et al. Melanoma incidence and mortality in Europe: new estimates, persistent disparities , 2012, The British journal of dermatology.
[416] Yun Zhou,et al. Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids. , 2010, Molecular pharmaceutics.
[417] Claus Garbe,et al. Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. , 2008, Advances in experimental medicine and biology.
[418] J. Kładny,et al. Common variants of DNA repair genes and malignant melanoma. , 2008, European journal of cancer.
[419] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[420] Hasan Mukhtar,et al. Impact of nanotechnology in cancer: emphasis on nanochemoprevention , 2012, International journal of nanomedicine.
[421] J. Wolchok,et al. Annals of the New York Academy of Sciences Development of Ipilimumab: a Novel Immunotherapeutic Approach for the Treatment of Advanced Melanoma , 2022 .
[422] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[423] Martin A Weinstock,et al. Cutaneous melanoma: public health approach to early detection , 2006, Dermatologic therapy.
[424] R. Millikan,et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. , 2006, Carcinogenesis.
[425] F. Noonan,et al. The effects on human health from stratospheric ozone depletion and its interactions with climate change , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[426] Yoshiyuki Hattori,et al. Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. , 2005, International journal of pharmaceutics.
[427] J. Brandner,et al. The skin: an indispensable barrier , 2008, Experimental dermatology.
[428] A. Testori,et al. Treatment of metastatic melanoma with electrochemotherapy , 2014, Journal of surgical oncology.
[429] A. S. Sobolev,et al. Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery , 2012, International journal of nanomedicine.
[430] C. Lawrence,et al. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma , 2002, British journal of plastic surgery.
[431] A. Sober,et al. Melanoma treatment update. , 2005, Dermatologic clinics.
[432] A. Nomizo,et al. Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin. , 2012, Journal of biomedical nanotechnology.
[433] Soumen Das,et al. Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. , 2010, Chemical communications.